Vesalius Biocapital offers venture capital
to young European innovative life science companies

logo
Portfolio News

Amakem

Amakem is using it’s Localized Drug Action platform for the development of kinase inhibitors. The primary focus is on eye disease.
Assets outlicensed

http://www.amakem.com/

Ophthalmology

Belgium

Investing phase